NCT02675907View on ClinicalTrials.gov

Evaluation of N1539 Following Bunionectomy Surgery

PHASE3CompletedINTERVENTIONAL

Enrollment

201

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions

Pain, Post-operative

Interventions

DRUG

N1539

DRUG

Intravenous Placebo

Trial Locations (4)

Unknown

Trovare Clinical Research, Bakersfield

Lotus Clinical Research, Pasadena

Chesapeake Research Group, Pasadena

Endeavor Clinical Trials, San Antonio

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Baudax Bio

INDUSTRY

NCT02675907 - Evaluation of N1539 Following Bunionectomy Surgery | Biotech Hunter | Biotech Hunter